Cormorant Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,080,000
| Closed | -$3.06M | – | 86 |
|
|
2016
Q1 | $3.06M | Hold |
1,080,000
| – | – | 0.46% | 53 |
|
|
2015
Q4 | $11.1M | Hold |
1,080,000
| – | – | 1.33% | 30 |
|
|
2015
Q3 | $12.3M | Buy |
1,080,000
+400,000
| +59% | +$4.56M | 1.97% | 14 |
|
|
2015
Q2 | $10.2M | Hold |
680,000
| – | – | 1.35% | 24 |
|
|
2015
Q1 | $6.14M | Sell |
680,000
-120,000
| -15% | -$1.08M | 0.95% | 35 |
|
|
2014
Q4 | $9.73M | Sell |
800,000
-300,000
| -27% | -$3.65M | 1.5% | 22 |
|
|
2014
Q3 | $10.8M | Sell |
1,100,000
-68,000
| -6% | -$665K | 2.21% | 10 |
|
|
2014
Q2 | $14.9M | Hold |
1,168,000
| – | – | 3.95% | 7 |
|
|
2014
Q1 | $12.4M | Buy |
1,168,000
+900,000
| +336% | +$9.52M | 2.84% | 14 |
|
|
2013
Q4 | $2.04M | Buy |
+268,000
| New | +$2.04M | 0.59% | 28 |
|